NeuShen Therapeutics
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
999 Huanke Road Bldg 12 5B, Shanghai, Sh...Website
www.neushen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About NeuShen Therapeutics
NeuShen Therapeutics is a global biotechnology company focused on discovering and developing novel therapies for psychiatric and neurological disorders. The company uses small-molecule discovery and AAV-based gene therapy platforms to advance innovative treatments for conditions including depression, schizophrenia, seizures, and neurodegenerative diseases.Explore more
NeuShen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuShen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
NeuShen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NeuShen Therapeutics is spiking on competitors!
Product Launch: Get notified when NeuShen Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at NeuShen Therapeutics
Check if NeuShen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once NeuShen Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NeuShen Therapeutics recently announced quarterly report
Click to see if NeuShen Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at NeuShen Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
NeuShen Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeuShen Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuShen Therapeutics.
NeuShen Therapeutics financials insights
Gather financial insights about NeuShen Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$20M
2026
Series B
$80M
NeuShen Therapeutics Tech Stack
A closer look at the technologies used by NeuShen Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Funding
NeuShen Therapeutics News & Media
NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia
SHANGHAI and LEXINGTON, Mass. , May 8, 2024 /PRNewswire/ -- NeuShen Therapeutics (the "Company"), a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today announced the dosing of the first healthy volunteer in Australia in the Phase I first-in-human clinical trial of NS-136, a novel selective M4 receptor positive allosteric modulator (M4 PAM) designed for the treatment of schizophrenia and other conditions associated withNeuShen Therapeutics Closes Approx. $20M Pre-A Financing
NeuShen Therapeutics, a Shanghai, China and Boston, MA-based biotechnology company focusing on developing treatments for central nervous system (CNS) disorders, raised approx. $20M in Pre-Series A funding. The round was led by Lapam Capital. The company intends to use the funds to expand the team and catalyze in-house CNS drug discovery in both the US and China. Led […] The post NeuShen Therapeutics Closes Approx. $20M Pre-A Financing appeared first on FinSMEs.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding NeuShen Therapeutics
Sign Up For FreeTo access detailed company insights
NeuShen Therapeutics is a global biotechnology company focused on discovering and developing novel therapies for psychiatric and neurological disorders. The company uses small-molecule discovery and AAV-based gene therapy platforms to advance innovative treatments for conditions including depression, schizophrenia, seizures, and neurodegenerative d... Read More
